Development of a Biomimetic Vitreous Substitute
Development of a Biomimetic Vitreous Substitute
批准号:
8826126
负责人:
Nathan RAVI
金额:
$36.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2017-03-31
关键词:
3-DimensionalAlkanesArchitectureBiodegradationBiological AssayBiomimeticsBlindnessCataractCell LineCircular DichroismClinicalClinical TrialsCollagenComplexCorneaDataDevelopmentDiseaseDisulfidesDrug Delivery SystemsDrug FormulationsEngineeringEvaluationExcisionExposure toEyeFibroblastsFluorocarbonsFourier TransformFutureGasesGelGlaucomaGoalsGrowthHealthHyaluronic AcidHydrogelsHydrophobicityImplantIn VitroIncidenceInflammationInjection of therapeutic agentInterventionKnowledgeLeadLight-Scattering SpectroscopyLiteratureMechanicsMethodsMissionModelingMolecularMolecular ProfilingMolecular WeightNatureNuclearNuclear Magnetic ResonanceOperative Surgical ProceduresOphthalmologic Surgical ProceduresOpticsOryctolagus cuniculusOsmotic PressureOutcomeOxygenPatientsPharmacotherapyPhysiologicalPhysiologyPlayPolymersPolysaccharidesPreventionPropertyPublic HealthRefractive ErrorsResearchResistanceRetinaRetinalRetinal DetachmentRheologyRoleSideSilicone OilsSodiumSodium ChlorideSolutionsStructureSulfhydryl CompoundsSurgical complicationSystemTechniquesTestingTranslatingUnited States National Institutes of HealthVisionVitrectomyWateranaloganterior chamberaqueousbasebiomaterial compatibilitycondensed matter physicscopolymercrosslinkdesignexpectationflexibilitygellanimprovedin vivoinnovationlight scatteringmethacrylamidenovel strategiesorganizational structureoutcome forecastpressurerepairedsuccesstissue culturetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Surgical removal of the vitreous and its replacement with substitutes has become the most common posterior segment eye surgery. Present substitutes, while functional, are temporary and are either absorbed (gases) or require secondary surgery for removal (silicone oils). Surgical complications include development of nuclear cataract, glaucoma, corneal decompensation, and retinal re-detachments. Our long-term objective is to deepen our understanding of the macromolecular organization of the vitreous components and then to use this information to develop more physiological vitreous substitutes that can exert an osmotic pressure to tamponade the retina. Our central hypothesis is that we can accomplish this by using water-soluble thiolated synthetic analogues of the collagen and hyaluronic acid, the two primary components of the vitreous. In our specific aims we will substitute collagen with deacylated gellan while hyaluronic acid will be substituted by a methacrylamide/sodium methacryate copolymer. Statistically designed polymers and their hydrogels will be characterized using nuclear magnetic resonance, Fourier transform infrared, raman, circular dichroism, and light- scattering spectroscopies, and rheology. Computational and macromolecular modeling techniques will be employed to study the relationship between the structure and mechanical properties of the natural vitreous. It is our expectation that the techniques will enable us to develop a 3-D molecular profile of the vitreous in vivo by using light
scattering techniques. Vitreous substitutes will be further tested by using light scattering, tisse culture and one-month in vivo rabbit studies followed by examination of the implant and histological evaluation of the retina. Our goal is to generate optimal biomimetic formulations of vitreous substitutes to be potentially translated into clinical interventions. This contribution wll be significant because these physiological gel substitutes could lessen patient burden by eliminating the need for removal of the substitute by secondary surgery, eliminating refractive error, possibly lowering the incidence of glaucoma and cataract postvitrectomy, and reducing redetachment of the retina. They could also be used to study the molecular mechanism of vitreous liquefaction and for intravitreal drug delivery therapies. The proposed research is innovative because it focuses on understanding and mimicking the natural vitreous and utilizing recent advances in soft condensed matter physics. Our two-component system representing rigid collagen and flexible hyaluronic acid will be endowed with sticky thiol groups. After injection of material as an aqueous solution, the rigid component will instantaneously form a physical gel imbedding the flexible copolymer. Upon subsequent exposure to oxygen, the thiol groups in the two components will form disulfide cross-links, resulting in a permanent hydrogel capable of providing osmotic pressure to tamponade the retina.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Topical Drug Delivery for Treating Macular Degeneration
-
批准号:10058218
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Nathan RAVI
-
依托单位:
Toxicology study of emissions from a burn pit simulator
-
批准号:10339413
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Nathan RAVI
-
依托单位:
Topical Drug Delivery for Treating Macular Degeneration
-
批准号:9889244
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Nathan RAVI
-
依托单位:
Topical Drug Delivery for Treating Macular Degeneration
-
批准号:10338098
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Nathan RAVI
-
依托单位:
Synthesis, Characterization and Biocompatibility of Hydrogel Vitreous Substitutes
-
批准号:8977425
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Nathan RAVI
-
依托单位:
Development of a Biomimetic Vitreous Substitute
-
批准号:8504450
-
项目类别:
-
资助金额:$32.97万
-
财政年份:2013
-
负责人:Nathan RAVI
-
依托单位:
Synthesis, Characterization and Biocompatibility of Hydrogel Vitreous Substitutes
-
批准号:8394329
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Nathan RAVI
-
依托单位:
Development of a Biomimetic Vitreous Substitute
-
批准号:8629747
-
项目类别:
-
资助金额:$39.76万
-
财政年份:2013
-
负责人:Nathan RAVI
-
依托单位:
海外基金